A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study will evaluate the efficacy and safety of petrelintide compared with placebo, in conjunction with a reduced-calorie diet and increased physical activity, for weight management in participants living with overweight or obesity and with Type 2 Diabetes (T2D).
Epistemonikos ID: 1beaa55c530c4c9ced1cc9314b5ff4e009518e98
First added on: Sep 29, 2026